BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4475217)

  • 1. [Unusual lipidosis caused by diethylaminoethoxyhexestrol (DH)].
    Nishikawa M; Yamamoto A; Shinshi Y; Kitani T; Adachi S
    Nihon Shokakibyo Gakkai Zasshi; 1974 Jul; 71(7):642-50. PubMed ID: 4475217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Outline of a specific disease caused by diethylaminoethoxyhexestrol (DH)].
    Nishikawa M
    Saishin Igaku; 1971 Nov; 26(11):2206-9. PubMed ID: 5141957
    [No Abstract]   [Full Text] [Related]  

  • 3. An electron microscopic observation on the cytological changes in the experimental drug-induced lipidosis.
    Tashiro Y
    Keio J Med; 1975 Apr; 24(2):115-43. PubMed ID: 1181474
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and experimental studies on phospholipidosis caused by diethylaminoethoxyhexestrol(DH)].
    Tsujii T; Matsumori T; Takahashi M; Sugioka T; Matsui T
    Saishin Igaku; 1971 Nov; 26(11):2242-50. PubMed ID: 5141966
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on drug-induced lipidosis. VI. Identification and determination of the drug and its metabolite in lipidosis induced by 4,4'-diethylaminoethoxyhexestrol.
    Matsuzawa Y; Yokomura T; Ishikawa K; Adachi S; Yamamoto A
    J Biochem; 1972 Sep; 72(3):615-21. PubMed ID: 4634972
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and pathological studies of patients treated with DH(diethylaminoethoxyhexestrol)].
    Kanetaka T; Oda T
    Saishin Igaku; 1971 Nov; 26(11):2224-7. PubMed ID: 5141961
    [No Abstract]   [Full Text] [Related]  

  • 7. Bis-(monoacylglyceryl)phosphate and acyl phosphatidylglycerol isolated from human livers of lipidosis induced by 4,4'-diethylaminoethoxyhexesterol.
    Kasama K; Yoshida K; Takeda S; Akeda S; Kawai K
    Lipids; 1974 Apr; 9(4):235-43. PubMed ID: 4364745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autopsy study of 2 patients treated with diethylaminoethoxyhexestrol].
    Saito K; Kitamura S
    Saishin Igaku; 1971 Nov; 26(11):2257-62. PubMed ID: 5141968
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies of patients treated with DH(diethylaminoethoxyhexestrol) for a long time].
    Furusawa S; Onozawa Y; Adachi Y; Hiejima K; Tsuchiya S
    Saishin Igaku; 1971 Nov; 26(11):2227-9. PubMed ID: 5141962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phospholipidosis caused by diethylaminoethoxyhexestrol].
    Matsuda Y; Ikegami F; Kobayashi K; Hasumura Y; Takada A
    Saishin Igaku; 1971 Nov; 26(11):2263-7. PubMed ID: 5141969
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-pathological studies on 7 cases suspected to have phospholipidosis and epidemiological studies on 116 cases given diethylaminoethoxyhexestrol(DH)].
    Sasaki H; Tanaka S; Kimura K; Ichida F
    Saishin Igaku; 1971 Nov; 26(11):2230-6. PubMed ID: 5141963
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on drug-induced lipidosis. 3. Lipid composition of the liver and some other tissues in clinical cases of "Niemann-Pick-like syndrome" induced by 4,4'-diethylaminoethoxyhexestrol.
    Yamamoto A; Adachi S; Ishikawa K; Yokomura T; Kitani T
    J Biochem; 1971 Nov; 70(5):775-84. PubMed ID: 5144610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic reactions caused by diethylaminoethoxyhexestrol and changes in clinical manifestations after withdrawing the drug].
    Adachi S; Seki K; Tato M; Horiuchi Y; Moriya T
    Saishin Igaku; 1971 Nov; 26(11):2250-6. PubMed ID: 5141967
    [No Abstract]   [Full Text] [Related]  

  • 14. [Specific lipoidosis caused by DH(diethylaminoethoxyhexestrol)-biochemical and pathological changes].
    Yamamoto A; Adachi S; Kitani T; Nasu T; Shinshi Y
    Saishin Igaku; 1971 Nov; 26(11):2209-14. PubMed ID: 5141958
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinico-pathological and electron microscopical studies on a coronary dilating agent: 4-4'-diethylaminoethoxyhexestrol-induced liver injuries.
    Ito S; Tsukada Y
    Acta Hepatogastroenterol (Stuttg); 1973; 20(3):204-15. PubMed ID: 4760403
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment.
    de la Iglesia FA; Feuer G; McGuire EJ; Takada A
    Toxicol Appl Pharmacol; 1975 Oct; 34(1):28-44. PubMed ID: 1198614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicopathological observations on 3 cases treated with a coronary dilator agent (4-4' diethylaminoethoxy hexoesterol dihydrochloride) for a long period, with special reference to autopsy findings].
    Shimamura K; Onozawa Y; Adachi Y; Furuzawa S; Hiejima K
    Naika; 1972; 29(2):344-51. PubMed ID: 5015106
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case of phospholipidosis considered to be caused by orally administered diethylaminoethoxyhexestrol(DH)].
    Takino T; Sakai Y; Shinraku M; Tanizawa Y; Hashimoto S
    Saishin Igaku; 1971 Nov; 26(11):2241-2. PubMed ID: 5141965
    [No Abstract]   [Full Text] [Related]  

  • 19. [3 cases of foam cell syndrome].
    Takahashi K; Miura A
    Saishin Igaku; 1971 Nov; 26(11):2214-7. PubMed ID: 5141959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Foam cell syndrome in bone marrow].
    Miura A; Shibata A; Akihama T; Endo Y; Takahashi K
    Rinsho Ketsueki; 1972 Oct; 13(5):769-76. PubMed ID: 4577427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.